Earnings Feed
Start Free
Anebulo Pharmaceuticals, Inc.·4

Jun 17, 4:23 PM ET

Lin Kenneth 4

4 · Anebulo Pharmaceuticals, Inc. · Filed Jun 17, 2024

Insider Transaction Report

Form 4
Period: 2024-06-13
Anebulo Pharmaceuticals, Inc.ANEB
Lin Kenneth
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-13+41,667→ 41,667 total
    Exercise: $2.10Exp: 2034-06-12→ Common Stock (41,667 underlying)
  • Award

    Stock Option (right to buy)

    2024-06-13+2,482→ 2,482 total
    Exercise: $2.10Exp: 2034-06-12→ Common Stock (2,482 underlying)
Footnotes (2)
  • [F1]These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
  • [F2]These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders

Documents

2 files